Matt Sause

CEO Roche Diagnostics (Member of the CEC since 2023)
Zur deutschen Version

Personal Data

Nationality
US

Year of Birth
1977

Education

1999
Microbiology at Miami University in Oxford, Ohio, B.A.

2006
Business Administration at University of California, San Diego, MBA

Professional experience

2002–2008
Roche Diagnostics, Various Account / Product Manager Roles

2008–2010
Japan / APAC, Tokyo, Commercial Operations Manager

2010–2012
Taiwan, Taipei City, Director Applied Science / Director Molecular Diagnostics 

2012–2014
Roche Diagnostics Ireland, Dublin, Country Manager

2014–2016
Roche Pharmaceuticals Peru, Lima, President / General Manager

2016–2018
Roche Pharmaceuticals Korea, Seoul, President / General Manager 

2018–2019
Genentech, USA, Vice President, Lifecycle Leader Tecentriq Lung and Head and Neck Cancers

2019
Gilead Sciences, Foster City, USA, Senior Vice-President, Head of Global Commercial Product Strategy

2019–2022
Roche Diagnostics Corporation North America, Indianapolis, USA, President & CEO 

Since 2023
Roche Diagnostics Basel, CEO, Member of the Corporate Executive Committee

Present external mandates

Other activities / non-profit activities / memberships

Since 2019
AdvaMed, Board Member

Awards / Honors


Möchten Sie den Inhalt auf Deutsch lesen?

Discover more

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

ContactLocationslinkedinfacebooktwitterinstagramyoutubeCovid-19Pharma solutionsRoche careersMedia libraryAnnual Report 2023Privacy policyLegal statement